Additionally, to address the oncogenic role of NIFK in HNSCC, shRNA was used to knock down the mRNA expression levels of NIFK in two HNSCC cell lines that are widely used, such as Cal27 and SCC25. The gene discussed is NIFK; the disease is head and neck squamous cell carcinoma.